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Background: Malignant pleural mesothelioma (MPM) is an uncom-
mon but extremely aggressive tumor of the pleura which has been 
closely linked to asbestos exposure. Over the last decade, a variety of 
receptor tyrosine kinases have been identiﬁed to play a central role in 
various aspects of tumorigenesis. One of these, EGFR, is overexpressed 
in the majority of MPMs and appears to play an important role in the 
pathogenesis of the disease. The aim of the present study was to inves-
tigate the potential value of tissue and serum EGFR for the diagnosis of 
MPM and to assess its predictive value in relation to survival.
Methods: We prospectively investigated 90 cases of pathologically-
proven MPM presenting at NCI Cairo. All cases were conﬁrmed using 
immunohistochemical markers. Epithelioid cases were positive to 
calretinine, mesothelioma antigen, keratin 5/6 and negative to epithelial 
membrane antigen and/or cytokeratin and/or CEA. Sarcomatoid cases 
were diagnosed by being positive for mesothelioma antigen and nega-
tive for vimentin. Out of the 90 MPM cases, 71 and 40 had undergone 
determination of the EGFR on the tissue and serum respectively. 
Results. Major clinical characteristics in MPM patients were: a median 
age 46, range (26-77) years, a M/F ratio 1.7:1, 28.2% of the cases were 
early stage, 35% had a performance status 2 and 70% gave a history 
of asbestos exposure. 57.8% of the cases were epithelioid, 23.3% were 
mixed, and 7.8% were sarcomatoid. Among all treated patients, the 
overall response rate (RR) was 32.8%. After a median follow up of 29 
months, the median overall survival (MOS) was 10 months. Using a 
cut-off point of 2.5 ng/ml for EGFR in serum (corresponding to the me-
dian of marker concentration in MPM), it was found to be signiﬁcantly 
associated with advanced stage. Using a normal cut-off value >0.23 
ng/ml, a borderline signiﬁcance with response to treatment was found. 
EGFR overexpression in tissues and high serum levels were not associ-
ated with unfavorable survival outcome. We have previously studied 
the correlation between EGFR overexpression EGFR in tissue samples 
in a subset group of this series for a shorter follow-up period (median 
follow-up), and we reported a highly signiﬁcant relation between 
EGFR expression and the OS rate. However, on a prospective, longer 
follow-up of these patients this signiﬁcant association was not revealed. 
Conclusions: 1- A high pretreatment levels of serum EGFR are associ-
ated with poor prognosis and unfavorable response to treatment but not 
with reduced OS. 2- Although increased EGFR expression in tissues 
is signiﬁcantly associated with OS rates in a short follow-up period, 
this signiﬁcant relation is not revealed on a long term follow-up. The 
explanation of this needs detailed genetic studies to determine the 
exact genetic defects (mutations or SNP) that might contribute to poor 
survival rather than protein overexpression.
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Background: Primary mass lesions arising from the mediastinum are 
uncommon. Their origins vary and they have multiple manifestations. 
Studies reporting these tumors are few and tumor registries provide an 
objective collection method to elucidate their characteristics.
Methods: A comprehensive review of all mediastinal lesions in the 
tumor registry of the Philippine Heart Center was undertaken and ana-
lyzed, which covered a 5-year period (2001-2006). 
Results: Seventy-nine mediastinal mass lesions from patients who 
underwent thoracotomy at our center were analyzed during the review 
period. Fifty-two (65.8%) were benign and the rest were malignant. 
Thymoma, 24 (30.4%) was the most common tumor in the series and 
was noted more on the female population. For the pediatric age group, 
the most common lesion was teratoma, 5 (55.6%). Non-Hodgkins 
lymphoma, 10 (12.7%) was the most common malignancy encountered 
in the entire population. Other pathologies encountered were mature 
teratoma, thymic carcinoma, Hodgkins lymphoma, thymic cysts, 
thymic carcinoid, teratocarcinoma, aberrant thyroid tissue, neurogenic 
tumors, vascular malformations, small cell carcinoma, lipoma, spindle 
cell tumor, bronchogenic cyst, and non-speciﬁc inﬂammatory lesion. 
Seventy-ﬁve (94.9%) of these tumors are located in the anterior medi-
astinum, 3 (3.8%) are in the posterior compartment, and only 1 (1.3%) 
arose from the superior portion. Immunohistochemical staining was 
done in most of the malignant lesions which included cytokeratin, CD 
3, CD 20, CD 15, CD 30, and LCA. The mean age was 39 (9 months 
- 87 years). There were 34 males (43%) and 45 females (57%). Nine 
(11.4%) belong to the pediatric age group (18 years old and below) and 
70 belong to the adult age group. Majority of these patients presented 
with dyspnea and cough. A few had incidental ﬁnding on routine radio-
logic examination.
Conclusion: Majority of the masses in the mediastinum arose from 
its anterior compartment and thymic lesions were mostly encountered. 
Thymomas constituted the majority of lesions among adults while 
teratomas predominate in the pediatric age group. Lymphomas were 
the most common malignancies in both populations. These differ-
ences should be considered when evaluating patients with mediastinal 
lesions. 
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Background: Promising results, even debated and not yet uniformly 
replicated, with trimodality treatment combining extra pleural pneumo-
nectomy (EPP), chemotherapy, and radiotherapy have been obtained in 
the management of malignant pleural mesothelioma (MPM). Neverthe-
less several prognostic parameters have to be taken into account before 
this aggressive management. Among them the histological subtype of 
the disease has an inﬂuence on the patient’s outcome with pejorative 
prognosis for non epithelial type. The aim of the present study was to 
retrospectively investigate the accuracy of thoracoscopy pleural biopsy 
for the diagnosis and histological subtype of MPM.
Methods: The histological reports of all consecutive patients undergo-
ing an ‘intention-to-treat’ surgery, i.e. EPP, pleurectomy (P), pleurec-
tomy/decortication (P/D) from three institutions as well as the initial 
pathological diagnosis obtained by thoracoscopy were reviewed and 
compared after institutional review board approval. All cases of MPM 
were conﬁrmed by a panel of pathologists (the “Mesopath” panel in 
France).
